pd-1 knockout t cells

Cell therapyexperimental

Clinical trial activity

8 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2016 (NCT02793856)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • pd-1 knockout t cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04417764Phase 1Jun 20, 2019Central South University
NCT03706326Phase 1/Phase 2 (Phase 2)Sep 28, 2018Guangdong Pharmaceutical University, Guangzhou Anjie Biomedical Technology Co., Ltd.
NCT03525652Phase 1/Phase 2 (Phase 2)Feb 22, 2018Guangdong Pharmaceutical University, University of Technology, Sydney
NCT03081715Phase 2Mar 20, 2017Anhui Kedgene Biotechnology Co.,Ltd, Chinese Academy of Medical Sciences
NCT02867345Phase 1Nov 1, 2016Cell Biotech Co., Ltd., Peking University
NCT02867332Phase 1Nov 1, 2016Cell Biotech Co., Ltd., Peking University
NCT02863913Phase 1Sep 1, 2016Cell Biotech Co., Ltd., Peking University
NCT02793856Phase 1Aug 1, 2016Chengdu MedGenCell, Co., Ltd., Sichuan University
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cell Biotech Co., Ltd.For profit3012016
Peking UniversityAcademic/Hospital3312016
Guangdong Pharmaceutical UniversityAcademic/Hospital2212018
Anhui Kedgene Biotechnology Co.,LtdFor profit1012017
Central South UniversityAcademic/Hospital1112019
Chengdu MedGenCell, Co., Ltd.Government1012016
Chinese Academy of Medical SciencesAcademic/Hospital1112017
Guangzhou Anjie Biomedical Technology Co., Ltd.Government1012018
Sichuan UniversityAcademic/Hospital1112016
University of Technology, SydneyAcademic/Hospital1012018
10 organizations
Page 1 / 1